CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
7 hedge funds and large institutions have $1.49M invested in Celyad Oncology SA American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$845K |
2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$60K |
3 |
Morgan Stanley
New York
|
+$4.74K |
Top Sellers
1 |
Victory Capital Management
San Antonio,
Texas
|
-$3.51M |
2 |
UBS Group
Zurich,
Switzerland
|
-$4.74K |
3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1K |